Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 16

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 16
---
                                                                                               
 Representative’s Warrants will provide for registration rights (including a one-time demand registration right and unlimited piggyback                                                                                                                                                                                                                                                                                                                                                                 
 rights) and customary anti-dilution provisions.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

<div align='center'>8</div>

| Use of proceeds: |     | We intend to use the net proceeds from this offering for working capital                                                       
 and general corporate purposes. See “Use of Proceeds” for a more complete description of the intended use of proceeds from     
 this offering.                                                                                                                 |
| Risk factors:    |     | Investing in our securities involves a high degree of risk. See “Risk                                                          
 Factors” beginning on page 10 for a discussion of the factors you should consider carefully before you decide to invest in our 
 securities.                                                                                                                    |
| Listing:         |     | Our                                                                                                                            
 Common Stock is listed on Nasdaq under the symbol “BIVI.”  There is no established                                             
 trading market for the Pre-funded Warrants or Warrants. The Warrants have been approved for listing                            
 on Nasdaq under the symbol “BIVIW”. We do not intend to list the Pre-funded Warrants                                           
 on any securities exchange or nationally recognized trading system and do not expect a trading market                          
 to develop for the Pre-funded Warrants.                                                                                        |

The number of shares of our Common Stock outstanding before this offering and to be outstanding after this offering is based on 1,860,086 shares of our Common Stock outstanding as of June 30, 2025, and excludes:

| · | 84,872 shares of our Common Stock issuable upon the exercise of outstanding 
 stock options at a weighted average exercise price of $ 286.20 per share;   |

| · | 960,098 shares of our Common Stock issuable upon the exercise of outstanding 
 warrants at a weighted average exercise price of $35.02 per share;           |

| · | 7,212 shares of our Common Stock issuable upon vesting of restricted 
 stock units issued under our equity incentive plan.                  |

Unless otherwise indicated, this prospectus supplement reflects and assumes the following:

| · | no exercise of outstanding options or warrants; |

| · | no exercise of the underwriters’ over-allotment option; |

| · | no exercise of the Pre-Funded Warrants and Warrants issued and sold in this offering; and |

| · | no exercise of the Representative’s Warrants to be issued upon consummation of this offering at an